Touchlight Completes Expansion of Large DNA Manufacturing Facility
Demand for DNA from biopharmaceutical companies is increasing exponentially.
Source: genengnews.com
📰 Jonny Ohlson News
Jonny Ohlson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jonny Ohlson. Real-time updates on events, politics, business and more.
Touchlight completes expansion, creating one of the world's largest DNA manufacturing facilities in London, UK
Touchlight, a company pioneering enzymatic DNA production, a critical material in many new genetic medicine treatments, has completed the redevelopment and expansion of its UK manufacturing facility, housed in a repurposed Victorian waterworks on the banks of the River Thames. The expanded state-of-the-art ...
Source: pharmiweb.com
Touchlight Completes Expansion, Creating One of the World's Largest DNA Manufacturing Facilities in London, UK
Facility will have capacity that exceeds today's global plasmid DNA demand and can enable commercialisation of genetic medicines. Transformation of Grade II-listed Victorian waterworks on the River
Source: finanznachrichten.de
Touchlight Signs Patent License Agreement With Pfizer for the Use of dbDNA for the Manufacture of mR
Pfizer and Touchlight agree to patent license for Pfizer to utilise rapid, scalable, enzymatic doggybone DNA (dbDNA) in Pfizer’s clinical and commercial manufacture of its mRNA vaccines, therapeutics, and gene therapiesAgreement includes upfront payment, potential development and commercial milestone payments, and r...
Source: pharmiweb.com
Touchlight Signs Patent License Agreement With Pfizer for the Use of dbDNA for the Manufacture of mRNA-based Vaccines, Therapeutics and Gene Therapies
Pfizer and Touchlight agree to patent license for Pfizer to utilise rapid, scalable, enzymatic doggybone DNA (dbDNA) in Pfizer's clinical and commercial manufacture of its mRNA vaccines, therapeutics
Source: finanznachrichten.de
Touchlight signs patent agreement with Pfizer
Deal involves the manufacturing of mRNA-based vaccines, therapeutics and gene therapies - News - PharmaTimes
Source: pharmatimes.com